In many normal developmental contexts, as well as in the context of neoplasia, beta-catenin signaling drives cell proliferation, and therefore one likely explanation for a reduction in DGCs is decreased cell proliferation secondary to reduced beta-catenin signaling in the cortical hem and adjacent medial cortex. Here, CTNNB1 is linked to neoplasm.